Reading the tape
NASDAQ: XRAY
DENTSPLY SIRONA Inc.
Healthcare · Medical - Instruments & Supplies
Market Cap
$2.22B
52w High
$17.18
52w Low
$9.85
P/E
-3.69
Volume
2.05M
Outstanding Shares
200.32M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -19.22%Revenue (TTM): -2.98%FCF (TTM): -62.99%P/FCF: 31st pct
What changed
The stock fell 19.22% over the last year. Revenue declined 2.98% over the trailing twelve months. Operating margin moved from -23.17% to 6.85%. Free cash flow declined 62.99% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 6.85%. A decisive move in revenue — currently down 2.98% — would be the clearest signal to resolve the ambiguity.
Company profile
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide.
CEODaniel T. Scavilla
SectorHealthcare
IndustryMedical - Instruments & Supplies
Employees14,000
IPO dateAug 12, 1987
Valuation
Forward P/E—
EV/EBITDA-96.11
Enterprise value$4.42B
Stock splits
Jul 18, 2006↑ Forward
Every 1 shares became 2
Feb 1, 2002↑ Forward
Every 2 shares became 3
Oct 30, 1997↑ Forward
Every 1 shares became 2
Aug 24, 1992↑ Forward
Every 1 shares became 2
Profitability & growth
Revenue growth6.19%
Gross margin50%▼3.14%vs FY2024
Operating margin6.85%▲129.55%vs FY2024
ROE-44.63%▲4.76%vs FY2024
Analyst consensus
RatingHold
Target price$13.40▲21.13%
12
Buy
18
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 5, 2026
Q2 FY26 · EPS est $0.28 · Revenue est $841.8M
View
Dividends
$0.64/shareQuarterlyDividend Aristocrat · 30yrStretchedXRAY pays a dividend with a 5.79% dividend yield, 30 consecutive years of growth, growing at 9.86% annually, covered 0.8× by free cash flow.
Dividend Yield
5.79%
Annual Div / Share
$0.64
5yr CAGR
+9.86%
Doubles every ~7.4yr
Payout Ratio
—
Stretched
Dividend Growth Rate
3yr CAGR
+8.58%
5yr CAGR
+9.86%
10yr CAGR
+8.26%
Dividend Safety
2/10Stretched
Dividend History
Annualized dividend cycles per share
YearAnnual DivYoY
2025$0.64+0.0%
2024$0.64+14.3%
2023$0.56+12.0%
2022$0.50+16.3%
2021$0.43+7.5%
2020$0.40+6.7%
2019$0.38+7.1%
Income Projection
Invest
$
Growth rate:
Reinvest dividends
Today
$58/yr
$5/mo
In 5 yrs
$93/yr+60%
$8/mo
In 10 yrs
$148/yr+156%
$12/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$58/yr $5/mo | $93/yr+60% $8/mo | $148/yr+156% $12/mo |
Yield-on-cost grows from 5.79% → 14.81% over 10yr
Analysis
Dividend Strengths
Dividend Aristocrat
XRAY has raised its dividend for 30 consecutive years — qualifying as a Dividend Aristocrat, demonstrating long-term commitment to shareholder income.
Strong dividend growth rate
The 5-year CAGR of 9.86% meaningfully outpaces inflation, compounding real income growth for long-term holders.
Risks to Watch
Dividend exceeds free cash flow
Free cash flow covers only 0.81× the dividend. The company is paying out more than it generates in cash, which is unsustainable without borrowing or asset sales.